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Epidermal Langerhans cells (LCs) possess surface 
markers and functional attributes which identify them 
as being of macrophage/monocyte lineage, and recent 
evidence documents their participation in certain im-
mune process which occur in skin. To assess the role of 
LCs in lupus erythematosus (LE), a disease in which 
immune system dysfunction predominates, human epi-
dermis from patients with cutaneous LE was studied 
with 3 LC surface markers: ATPase activity, HLA-DR 
and OKT-6 antigens. Suction blister top epidermal skin 
biopsies from patients with 3 clinical types of cutaneous 
LE exhibited similar features: LCs were less dendritic, 
they were more irregularly distributed, and they were 
present in fewer numbers when compared with those in 
adjacent normal skin. These changes contrasted with 
those observed in diseases with similar lichenoid histo-
pathological features. LCs appeared increased in num-
ber in lichen planus. LCs in skin lesions from one patient 
with dermatomyositis exhibited similar morphologic al-
terations, but surface densities and distributions were 
preserved. Disaggregated epidermal cells from skin le-
sions of patients with cutaneous LE induced allogeneic 
lymphocyte proliferation as efficiently as did cells from 
nonlesional skin, indicatiQg that the morphologic alter-
ations observed were not associated with a decreased 
alloantigen presenting capacity. These studies have 
demonstrated that epidermal LC populations in 3 clinical 
types of cutaneous LE are perturbed in a manner not 
seen in 2 other lichenoid skin diseases, although these 
changes were not associated with an altered capacity of 
such cells to stimulate proliferation by allogeneic lym-
phocytes. 
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Seventy percent of patients with systemic lupus erythema-
tosus (SLE) will at some point in their cow'se develop some 
type of skin disease and clinically distinctive inflammatory skin 
lesions (lupus specific skin disease) ultimately will occm in 55% 
of SLE patients [I). In addition lupus specific skin disease such 
as discoid LE (DLE) frequently occms in patients who never 
develop systemic manifestations of LE. Because of the accessi-
bility of such lesions for biopsy, the underlying histopathologic 
alterations have been well described and most frequently in-
clude hyperkel'atosis, follicular plugging, epidermal atrophy, 
basaloid keratinocyte liquifaction degeneration, basement 
membrane thickening and a dermal perivascular mononuclear 
cell infiltrate. These alterations form characteristic histological 
patterns which are of diagnostic value even though the under-
lying pathogenetic mechanisms remain obscure. Since numer-
ous autoimmune alterations characterize systemic LE, it has 
been assumed that the cutaneous manifestations have an au-
toimmune etiology as well. In studies designed to assess the 
contribution of immune processes to cutaneous LE, we have 
focused our attention on epidermal Langerhans cells (LCs). 
This has been done in view of recent evidence from murine 
studies which implicates LCs as playing a pivotal role in antigen 
presentation by epidermal cells in cutaneous allograft recogni-
tion [2] and in contact hypersensitivity [3]. Furthermore, stud-
ies with human epidermal cells demonstrate that only LCs 
participate actively in immunological processes such as antigen 
presentation [4). We have consequently used 3 techniques to 
examine LC distribution and morphology in lesional and con-
tiguous nonlesional skin specimens from 7 patients with selected 
clinical types of cutaneous LE. The results of these studies 
clearly demonstrate that the LC populations are indeed per-
turbed in this disease process. 
METHODS 
Pa.tient Selection. 
Seven patients with cutaneous LE were studied. Five Caucasian 
women had active subacute cutaneous lupus erythematosus (SCLE) , a 
widespread, nonscarring and frequently photosensitive form of cuta-
neous LE [5]. Three of these patients exhibi ted the papulosqua mous 
pattern and 2 exhibited the a nnulru' pattern. Two Black women had 
typical, scarring, active DLE. As disease cont.rols 1 Black man and 1 
Black woman with typical lichen planus and 1 Caucasian woman with 
severe skin changes of dermatomyositis were a lso studied. None of 
these 10 patients had been treated with either topical or intralesional 
corticosteroids for at least 3 weeks prior to the time of study. One 
SCLE patient was receiving prednisone 30 mg per day orally a nd 
another SCLE patient was receiving hydroxychloroquine 200 mg per 
day orally at the time of study. Informed written consent was obtained 
from each patient. 
Studies on ""hole Epidermal Sheets 
Five sepru'ate 7-mm diameter vacuum-induced blisters were raised 
simultaneously over smgically prepared lesional and contiguous nonle-
sional skin with a Dermovac unit (In trumentru'ium, Helsinki, Finland). 
In 3 SCLE and 2 DLE patients, nonlesional epidermis was taken ~rom 
the same anatomic region as lesional epidermis. In the other 2 patients 
(1 with papulosquamous SCLE and 1 with annulal' SCLE) it was 
necessary Lo obtain nonlesional epidermis from fiexor rather than 
extensor aspects of their forearms because of the extensive confiu ence 
of lesions over the extensor smfaces. In 2 SCLE patients both lesional 
and nonlesional epidermis was obtained from their upper backs, a 
238 SONTHEIMER AND BERGSTRESSER 
relatively sun-protected a natomical region. In the remaining 5 patients 
it was necessary to take the epidermal specimens from more sun-
exposed sites, the upper arm and fo rearm. Blisters over nonlesiona l 
skin were produced 3-5 cm away from the margin of the active lesions. 
Complete blisters formed after approximately 2 hJ' of 200 mm Hg 
vacuum with gentle heating from a Westinghouse Heat Ray Infrared 
lamp. Each blister top, consisting entirely of epidermis, was then 
removed with sterile iris scissors and forceps without anesthesia. Spec-
imens were washed in Hanks' balanced salt solu t ion (HBSS) and 
processed histochemically for adenosine triphophatase activity (ATP-
ase) or by indirect immunofluorescence (IF) technique for HLA-DR 
antigen. Selected epidermal sheets were clisaggregated in trypsin to 
produce suspensions of single epidermal cells which were then used as 
stimulators in mixed epidermal cell-lymphocyte cultures. 
Adenosine Triphosphatase (A TPase) Activity 
Whole sheets of epidermis were stained histochemically for cell 
surface ATPase activity with the method described by Bergstresser, 
Fletcher, and Streilein [6]. P lasma membranes of LCs possess high 
concentrations of this enzyme, making it a reliable marker for the 
presence of such cells in the epidermis (7]. Lesional and nonlesional 
epidermal sheets from each patient we re processed in parallel fashion 
on the same day, and the surface density of ATPase posit ive LCs in 
each epidermal whole mount was determined visually with a ligh t 
microscope equipped with a calibrated ocular grid [6]. All slides were 
read by the same observer in a blinded fashion . 
Indirect IF (or liLA-DR Antigen 
Whole blister top epidermal sheets were fixed in acetone for 5 min 
then washed in HBSS. Speci mens were then incuba ted at 4°C for 18 hr 
in a 1:100 dilution with phosphate buffered saline (PBS) of a mouse 
monoclonal antibody which is specific for a n antigen common to all 
human HLA-DR molecules (#243; Beckton Dickinson, Sunnyvale, 
Ca.). Epidermal sheets were again washed and incubated in a fluores-
cein isothiocyanate (FITC) conjugated goat anti-mouse immunoglob-
ulin (Ig) (Meloy, Springfield, Va.) at a 1:10 dilution (PBS) at 23°C fo r 
1 hr on a rocking platform . After a fina l wash they were placed on glass 
slides, covered with 90% glycerol-l0% PBS mounting medium and 
examined with a Leitz Ortholux microscope equipped for epi-illumina-
tion. Control epidermal sheets stained with the FITC-conjugated goat 
anti-mouse Ig a lone did not show fluorescence staining. Normal mouse 
serum substituted for the monoclonal antibody also did not produce 
fluorescence staining. 
Indirect IF (or the OKT·6 Antigen 
Four-mm punch biopsies were taken from lesional and nonlesional 
skin and snap frozen in T issue Tek embedd ing medium (Lab-Tek 
Products, Naperville, III.) for cryostat sectioning. Four micron sections 
were made and placed onto glass s lides fo llowed by fixa tion with 95% 
ethanol for 15 min. Sections were then incubated at 23°C for 30 min 
with a 1:10 PBS dilution of the OKT-6 monoclonal antibody (Ortho 
Pharmaceuticals, Raritan, N.Y.), washed in PBS, then incubated for 30 
min at 23°C in the FITC labeled goat antimouse Ig a nd washed a 
second time in PBS. Specimens were then !1ooded with the 90% 
glycerol-lO% PBS mounting medium a nd examined with the flu ores-
cence microscope. 
Mixed Epidermal Cell· Lymphocyte Reaction (MECLR) 
One way, primary cultw'es of stimulator epidermal cells and alloge-
neic responder peripheral blood mononuclear cells (PBMC) w.ere set 
up in the fo llowing manner. Blister top epidermal sheets were incubated 
in 0.3% tryps in solu tion for 30 min at 37°C and then gently agitated at 
5-min intervals over the next 30 min to give a single cell suspension. 
After wash ing in HBSS and a 5-min exposuJ'e at 23°C to 0.025% 
deoxyribonuclease (Sigma, St. Louis, Mo.) to prevent mucoid reaggre-
gation, the epidermal ce lls were filte red through sterile nylon mesh and 
then resuspended in RPMI 1640 medium supplemented with 2 mM 
fresh L-glu tamine, 15% heat inactivated pooled human AB serum, 
penicillin 400 units/ml, streptomycin 500 ,.g/ ml and fungizone l,.g/ml 
(Gibco, Grancl Island, N.Y.). Cell yield was then determined in a 
hemocytometer and the ce ll suspension was exposed to 4000 rads of 
gamma irradiation from a Cesium"l7 source. Viabili ty was then deter-
mined with a fluJ'Oescein diacetate-ethidium bromide assay [8]. PBMC 
were prepared by lsolymph (Galiard.Schlesinger Chemical Co., Carle 
Place, N.Y.) density gradient centrifugation. Mixed cultures of epider-
mal cells and PBMC were then set up in round bottomecl microtitre 
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wells (Dyantech, Alexandria, Va. ). The cul tw'es consisting of 6 X 10" 
viable epidermal cells and 1 X 10" viable PBM C were incubated for 144 
hI' in a humidified 5% CO2 atmosphere at 37°C. E ighteen how's prior to 
harvesting each cul ture was pulsed with 1 ,.Ci of tri t iated thymidine 
([3H]TdR). After washing, cells were collected with a MASH II auto-
mated ce Ll harvester onto glass fiber fllters and the amount of incor-
porated label determined by liquid scint illation spectroscopy. All cul -
tures were done in trip licate with the resul ts expressed as mean counts 
per minute (CPM) ± 1 SD. Data was expressed as the tJ. CPM (CPM 
of cul tures conta ining both stimulato r and responder cells minus the 
sum of the CPM of the stimulator a nd responder cell popula tions 
cul tured separately) or as the stimulation index (S1) (CPM of cul tures 
containing both stimu lator and responder cells divided by the combined 
CPM for stimulator and responder cell populations cul tured sepa-
rately). 
RESULTS 
Production of Suction Blisters Over Cutaneous LE Shin 
Lesions 
In all patients, blisters were raised successfully over erythem-
atous, active portions of their skin lesions. The time required 
for blisters to form was approximately 2 hI' for both lesional 
and nonlesional skin. Microscopic examination of blister tops 
revealed the plane of cleavage in nonlesional skin to be the 
dermal-epidermal (D-E) junction, leaving the epidermal basal 
cell layer intact. However, lesional skin was cleaved through 
the damaged epidermal basal cell layer as well as the D-E 
TABLE I. Characteristics o( epidermal cell suspensions derived (rom 
suction-induced blister tops in cutaneous LE 
Patient Cell yield (XIOH) Viability (%) 
groups Lesion Nonlesion Lesion Nonlesion 
SCLE 
S.J . (a) 0.57 0.78 93 95 
(b) 1.27 1.86 92 93 
P .J. 0.73 0.80 89 90 
DLE 
C.B. 0.54 1.52 92 93 
RT. 0.73 0.54 77 89 
-FIG 1. A, Non lesional epidermal sheet whole mount fi'o m a patien t 
with papulosquamous SCLE processed for ATPase activity. Note the 
regularly distr ibuted da rkly staining ATPase posit ive cells that possess 
primary, seconda ry a nd ter t iary dendrites. B, Corresponding lesiona l 
epidermal sheet whole mount from the same patient shown at the same 
magnification. Note the more irregu lar distribution of ATPase posit ive 
cells and the paucity of denw'ites on these cells (reduced !i'om X 2350) . 
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junction. Trypsin disaggregation of blister tops consistently 
produced epidermal cell suspensions with high viabilities (Table 
1) . Viabilities of lesional and nonlesional epidermal cell suspen-
sions were similar. 
ATPase Staining of Suction Blister·derived Epidermal 
Sheets 
The typical appearance of an ATPase stained nonlesional 
epidermal sheet whole mount from a patient with papulosqua-
mous SCLE is shown in Fig lAo All ATPase-positive cells were 
dendritic; both primary and secondary dendrites were always 
present, and tertiary dendrites were seen often. Corresponding 
lesional epidermis from the same patient is shown at the same 
magnification in Fig lB. Most of the dru:kly staining ATPase' 
positive cells were rounded and for the most part were without 
dendrites. Those few cells which possessed dendrites usually 
had only large primary ones. These changes are chru:acteristic 
of LGs found in all lesional specimens. The intensity of the 
ATPase reaction in this and in all lesional specimens was 
generally less than that seen in nonlesional epidermis. In addi-
tion, ATPase positive cells had a disordered distribution when 
compared with the monotonously regulru' distribution ofLCs in 
nonlesional epidermis. Some areas were completely devoid of 
ATPase positive cells in the lesional epidermis. Occasionally, 
single, very large, elongated, bizarre-appearing dendritic cells 
were seen in the lesional epidermis. These abnormalities were 
qualitatively the same in both clinical forms of SCLE as well as 
in DLE. The ATPase positive LCs of the patients receiving 
prednisone or hydroxychioroquine were similar in both lesional 
and nonlesional skin to those of the other patients. Table II 
compares mean densities of ATPase positive LCs in the nonle-
sional and lesional epidermis of the 3 SCLE patients in whom 
adequate tissue was available for study. In each patient lesional 
densities were less than the nonlesional. In one patient with 
dermatomyositis lesional and nonlesional densities were not 
different, although LCs were much less dendritic in lesional 
epidermis. 
Demonstration of HLA ·DR Bearing Cells in Suction Blister 
Derived Epidermal Sheets 
To determine whether the changes seen with ATPase activity 
represented only a nonspecific inflammation-induced pertur-
bation in membrane ATPase activity we employed a second 
method to visualize LCs in suction blister-derived epidermal 
sheets. Taking advantage of the observation that LCs are the 
only epidermal cells which synthesize and express HLA·DR 
antigens, we developed a method for visualizing this antigen in 
epidermal sheets obtained from suction blisters. Figure 2 rep-
resents a whole mount of nonlesional SCLE epidermis that has 
been reacted with the HLA-DR antibody (#243) followed by a 
FITC conjugated ant imouse Ig. Numerous brightly fluorescing 
cells ru,'e present in a regular distribution and close inspection 
reveals each cell to possess several faint dendritic processes. 
Figure 3 represents lesional epidermis from the same patient 
processed in parallel by the same technique and shown at the 
same magnification. LCs from lesional skin ru'e fewer in number 
and have fewer dendritic processes. 
TABLE II. Epidermal Langerhans cell (ELC) density in cutaneous 
lupus erythematoslis 
Patient 
groups 
SCLE 
S.J. 
P.J. 
RC. 
Dermatomyositis 
B.N. 
Mean ATPase Positive ELC/ mm' (± 1 SD) 
Nonlesional Lesion,,1 
396 ± 36 159 ± 47 
461 ± 64 347 ± 65 
390 ± 70 70 ± 29 
545 ± 97 507 ± 51 
FIG 2. Fluorescence microscopy appearance of a nonlesiona l epider. 
mal sheet whole mount from a papulosquamous SCLE patient after 
reaction with a mouse monoclonal antihuman HLA-DR an tibody 
(#243) followed by a FITC·conjugated goat antimouse Ig. Note the 
regular distribution of the brightly fluorescing dendritic, HLA·DR 
bearing cells (reduced from X 2350) . 
Demonstration of Epidermal Langerhans Cells on Cryostat 
Sections of Punch Slein Biopsies 
We attempted to examine lesions of lichen planus with the 
same techniques as a disease control in which a mononucleru' 
cell infiltrate exhibits a lichenoid pattern similru' to that seen in 
cutaneous LE. However, because of mechanical difficulties en-
countered in raising suction blisters over the small, discreet 
lesions which occur in this disease, we elected to use the OKT-
6 monoclonal antibody on cryostat sections of punch biopsies. 
Edelson and his associates [9] have shown that this antihuman 
thymocyte antibody reacts specifically with human LCs but not 
with other epidermal cells or with ci.rculating PBMC. Figure 4 
shows the apperu'ance of an ethanol fixed cryostat section of 
lichen planus lesional skin which has been exposed first to the 
OKT-6 monoclonal antibody and then to FITC conjugated goat 
antimouse Ig antiserum. Numerous brightly fluorescing epider-
mal dendritic cells apperu' in the supra basilar position. Com-
pru'ed with nonlesional skin from the same patient (not shown) 
there appeared to be increased numbers of OKT-6 positive 
epidermal dendritic cells in lesional skin. Similal' results were 
seen in the second patient with lichen planus. Figure 5 shows at 
the same magnification the appearance of a DLE skin lesion 
processed similarly. Many fewer OKT·6 positive epidermal 
dend.ritic cells were seen here than in lichen planus. In addition, 
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OKT-6 positive cells were less numerous, less dendritic and 
present higher in the epidermis compared with those in the 
nonlesional skin of the same patient (not shown). We conclude 
that these morphologic alterations in cutaneous LE lesions 
represent specific changes rather than a simple response to 
inflammation or basal cell layer injury since contrasting alter-
ations were seen in lichen planus, a disease in which a similar 
pattern of basal cell injury occurs. 
Mixed Epidermal Cell-Lymphocyte Reaction 
Epidermal cells from humans and laboratory animals can 
substitute for lymphocytes as stimulator cells in the mixed 
lymphocyte reaction [10-13]. Evidence from animals [14] and 
man [4,15] suggests that Ia- (or DR) positive LCs are primarily 
responsible for producing allogeneic lymphocyte stimulation. 
For these reasons we used the primary allogeneic MECLR to 
assess the function of LCs from lesions of cutaneous LE. In 
these studi~s paired whole suspensions of epidermal cells from 
lesional and nonlesional skin were cocultured with responding 
PBMC from an unrelated normal donor. Differences in the 
blastogenic response produced by the lesional and nonlesional 
epidermal cell populations could reflect differences in the func-
tional state of the stimulating HLA-DR positive LCs. Table III 
lists the results of 5 experiments with cells from 4 patients (2 
FIG 3. Fluorescence microscopic appearance of a lesional epidermal 
sheet whole mount from the same SCLE patient as in Fig 2, processed 
in a similar fashion and shown at the same magnification. Note the 
sparce and inegular distribution of (he HLA-DR bearing cells which 
are for the most part devoid of dendrites (reduced from X 23qO). 
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FIG 4. Fluorescence microscopy appearance of a 4 fL ethanol-fixed 
cryostat section from a punch biopsy of lichen planus lesional skin a fter 
reaction with the mouse monoclonal OKT-6 antibody fo llowed by a 
FITC conjugated goat anti-mouse Ig. Top row of arrowheads indicates 
the position of the stratum corneum. Bottom. row of arrowheads 
indicates the posit ion of the dermal-epidermal junction. Note the 
numeJ'Ous dendritic OKT-6 positive cells in the suprabasila r and mid 
epidermal areas (reduced from X 3770). 
with DLE, 2 with the annular form of SCLE). Lesional epider-
mal cells from all 4 patients produced significant allogeneic 
stimulation with stimulation indicies as high as 101. Further-
more, there was no consistent relationship between the amount 
of stimulation produced by lesional and nonlesional epidermal 
cells. Lesional epidermal cells from 1 SCLE patient, S.J., pro-
duced lower stimulation indicies than did nonlesional cells; 
whereas, lesional and nonlesional epidermal cells from the 
second SCLE patient, P .J., produced equivalent stimulation. 
Lesional epidermal cells f-rom both DLE patients produced 
greater stimulation than did nonlesional cells. Finally, lesional 
and nonlesional epidermal cells from all patients consistently 
produced significantly greater amounts of allogeneic stimula-
tion than did autologous PBMC. We have made this observa-
tion previously with epidermal cells taken fTom a large group of 
normal subjects [15]. This heightened capacity of epidermal 
cells to produce allogeneic stimulation may result from an 
inherently greater alloantigen presenting efficiency ofla bearing 
dendritic ce lls in comparison with Ia positive PBMC [16]. 
Since all these studies were conducted with 5 X 104 stimulator 
cells, a number which with normal epidermal cells in our system 
produces maximal stimulation , we investigated the possibility 
that lower stimulator-responder ratios (and therefore submax-
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FIG 5. Fluorescence microscopy apperu'ance of DLE Ie ional skin 
proces ed in the same manner as in Fig 4 a nd shown at the same 
magnifica tion. Note that there ar e fewer OI<T-6 positive cells in the 
DLE lesional epidermis and that those present are in the mid and 
upper epidermis. The arrowheads indicate the same levels as in Fig 4 
(reduced from X 3770). 
TABLE III. Allogeneic lymphocyte stimulatin.g capacity of lupus 
erythetnatoslis epiderm.al cells (E C) 
["H]TdR Incorporation by 10" Allogenic Responder PBMC 
Patient 
groups Lesional E.C. Nonlesional E.C. PBMC 
(5 X 10"') (5 X 10") (5 X 10") 
SCLE 
S.J . (II ) 47928 ± 1894" (83.4") 63 105 ± 8276 (109.0) 14678 ± 5702 (28.0) 
(b) 21894 ± 999 (4 1.0) 44083 ± 5883 (87.8) 9016 ± 2252 (17.9) 
P.J . 54629 ± 53il (57.1) 54549 ± 7655 (56.6) 27058 ± 2328 (28.8) 
DLE 
C.B. 87651 ± 14780 (65.5) 49757 ± 3837 (36.6) 19183 ± 6608 (I 5.1) 
R.T. 59845 ± 4852 (l01.0) 58664 ± 2516 (89.4) N.D. 
" Llcpm ± S O. 
I, Stimu lation Index. 
imal stimulation) would reveal more subtle differences in the 
alloantigen presenting capacities of lesional and nonlesional 
epidermal cells. To address this question, 2 experiments were 
conducted in which allogeneic stimulation was measured by 
employing decreasing numbers of lesional and nonlesional stim-
ulator cells. In the first experiment (Fig 6) lesional epidermal 
cells from a patient with the an nular form of SCLE (S.J .) did 
produce somewhat less s timulation at high stimula tor-re-
sponder cell ratios while at lower ratios this difference disap-
peared. In contrast lesional cells from a DLE patient (C.B.) 
produced higher stimulation at higher stimulator-responder 
ratios with no differences at lower ratios (Fig 7). As noted 
previously lesional and nonlesional epidermal cells in each of 
these experiments produced much greater stimulation than did 
autologous PBMC at the same stinlUlator-responder ratios. 
DISCUSSION 
Deposits of immunoglobulin and complement components 
occur frequently at the D-E junction in lesions of cutaneous 
LE, and because of this phenomenon, investigators have as-
sumed that clinical lesions as well as the underlying histopath-
ologic alterations result from antibody- or immune complex-
mediated autoimmune injUJ'Y. Despite the attractiveness of this 
hypothesis, several observations argue against it [17]. Most 
important among these is the observation that in1l1lUnogiobulin 
and complement deposits also occm at the D-E junction in the 
clinically normal-appearing skin of patients with systemic LE. 
Moreover , the clinical expression of cutaneous LE is consist-
ently linked through histopathologic observations to an infli-
trate of mononuclear lymphoid cells in a bandlike or lichenoid 
pattern in the upper dermis. It is considerably more likely, 
therefore, that the epidermal changes result from an autoim-
mune attack by specifically sensi tized l' -lymphocytes [17]. This 
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hypothesis gains further support from the clinical and histo-
pathologic similarities of skin injury in cutaneous LE and graft-
versus-host disease, both experimental [18] and human [19]. By 
extension, this hypothesis implicates epidermal LCs as playing 
a role in that process since they possess important immunolog-
ical characteristics: Fc and C3b receptors, plasma membrane 
HLA-DR antigens, and the capabili ty to present antigen. 
Our studies suggest strongly that epidermal Langerhans cells 
play a role in the process which results in cutaneous LE. 
Langerhans cells in inflammatory cutaneous lesions of SCLE 
and DLE were examined by three histochemical and immuno-
chemical techniques: cell surface ATPase activity, HLA-DR, 
and OKT-6 antigens. By each technique LCs exhibited pro-
fo und morphologic alterations when compared with those in 
clinically normal skin from the same patients. Most important 
among these changes were reduced surface densities, loss of 
dendritic processes, and the occasional presence of cells with 
bizarre shapes. Specimens from patients with DLE and 2 forms 
of SCLE were indistinguishable from each other and were easily 
distinguished from 2 other cutaneous disorders in which au-
toimmune phenomena predominate, dermatomyositis and li-
chen planus. E longated and bizarre LCs which were seen oc-
casionally were similar in appearance to those described in 
PUVA-treated psoriatic skin by Juhlin and Shelly [20]. That 
report also described similarly abnormal LCs in one DLE 
patient. By studying epidermal sheet whole mounts, we have in 
addition demonstrated diminished densities and distorted dis-
tributions of LCs in the three SCLE patients studied. It is not 
likely that these density alterations resulted from variations in 
the level of separation during blister form ation, since histolog-
ical examination demonstrated separation to occur through 
eith er the injured epidermal basal cell layer or through the D-
E junction. Separation did not extend into the suprabasilar 
location where LCs reside. Furthermore, decreased densities in 
OKT-6 positive cells in the cryostat sections of punch biopsies 
from lesional skin confirm th e findings as well. In dermatomy-
ositis skin lesions from one patient no decrease in LC density 
was seen, although morphologic alterations did occur. In con-
trast, lesions of lichen planus had equivalent or even increased 
numbers of LCs in lesional skin. Tjernlund's previous work in 
this area has shown at least normal numbers of HLA-DR 
positive LC in lesions of lichen planus [21]. Ragaz and Acker-
man h ave also suggested that LCs are increased in number in 
lichen planus lesions [22]. 
The morphological and density alterations that we have 
observed in the LCs of cutaneous LE lesions were not associated 
with decreased alloantigen presenting capacities of whole epi-
dermal cell suspension taken from these lesions. The difficulty 
of isolating viable LCs was the reason that we used whole 
epidermal cell suspensions as stimulator cells in these studies. 
This was a justifiable approach, however, since we have shown 
pre~iously in ~locking studies t hat t he HLA-DR positive LCs 
(which compnse only 4-5% of whole epidermal cell suspensions) 
are responslble for at least 80% of th e allogeneic blastogenesis 
prod.uced by whole epidermal cell suspensions [15]. It is still 
posslble that our results might have been different had we been 
abl.e to compare the. alloantigen presenting capacities of purified 
leslOnal and nonleslOnal LC populations; however , this is tech-
nically not possible at this time. It is also possible that HLA-
DR positive PBMC capable of alloantigen presentation (i.e., 
monocytes) could have infiltrated the epidermis as a result of 
the inflammatory reaction in the lesional skin. Such contami-
nating cells would have been carried over into the blister top 
epidermal cell suspensions and might have enhanced signifi-
cantly the magnitude of the MECLR response produced by the 
lesional skin . T his would narrow any MECLR differences be-
tween lesional and nonlesional epidermis if functional abnor-
malities in lesibnal LCs did exist. It is also possible that our 
method is not sensitive enough t'o detect subtle alloantigen 
presenting differences between separate LC populations. Ow, 
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own studies have shown that as few as 2"00 epidermal cells (in 
which there would be only 8 to 10 LCs) will produce significant 
blastogenesis in 105 allogeneic responding PBMC (unpublished 
personal observation). Thus, this cell type might be too effi cient 
in alloantigen presentation for this characteristic to be a useful 
discriminator between normal and perturbed populations of 
LCs. It might also not be justifiable to assume that alloantigen 
presenting capacity accurately reflects nonalloantigen present-
ing capacity in a cell type such as the LC. Thus, measurements 
of the contrived, unnatural MECLR might not accurately re-
flect a perhaps more physiological role of presentation of non-
alloantigens to autologous T cells. 
Since the normal physiological functions of LCs are not 
known, it is difficult to assign a contribution of LC alterations 
to the pathogenesis of LE skin disease. Because of its antigen 
presenting characteristics the LC might playa role in immu-
nosurveillance in skin. The epidermis is a highly proliferative 
cellular compartment that interfaces with the envu'onment and 
as such has a significant potential for sustaining mutational 
injury. It is thus possible that the LC is responsible for the 
recognition and/or elimination of newly formed, abnormal epi-
dermal antigens (i.e., ultraviolet light-induced antigenic 
changes). A logical extension of this argument would include 
the possibility that LCs might bind normally present epidermal 
antigens and thus become part of the target complex of auto-
reactive T cells in an autoimmune disease process such as LE. 
As such a paJ·ticipant, the LC might be expected to be altered 
morphologically in a manner perhaps similar to that which we 
have shown. However, the possibility cer tainly exists that the 
changes in LC morphology and density that we have seen could 
be completely secondary to umelated processes that are re-
sponsible for LE skin lesions. 
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Cutaneous Blood Flow during White Dermographism in Patients with 
Atopic Dermatitis 
PER KLE MP M.D., AND B E NT S TABE R G, M .D. 
Departments of Dermatology and Clinical Physiology, The Finsen In stitute, Copenhagen, Delim aI''' 
Cutaneous blood flow was d e termined b efore and im-
m ediate ly afte r rubbing the skin of7 patie nts with atopic 
d e rmatitis and 6 normal s ubject s , using the local a trau-
matic I:J:lXe-me thod. In the a topic patients the rubbing of 
eczematous skin produce d white dermographis m and 
s imultaneously the cuta neous blood flow decre a sed in 
all the patients from 15.2 ± SEM 1.7 ml/ l00 go min b e fore 
the rubbing to 6.2 ± SEM 1.6 ml/ l00 gomin during white 
d e rmographism (p < 0.002). In all the normal s ubjects 
the rubbing stimulus w as followed b y an incre a se in 
blood flow from 5.2 ± SEM 0.6 to 24 .4 ± SEM 3.1 ml/l00 
go min (p < 0.001), although r e d d e rmographism was not 
seen in a ll. 
It i s conclude d that the most r e a sonable e xpla nation 
for the pallor during white d e rmogra phis m is the r e -
duce d cutaneous blood flow. 
Rubbing t h e ecze ma tous s kin of pa tien ts wit h atopic derma-
titis commonly produces white dermographism [1], while nor -
mal skin m ay rea ct to rubbing by becoming red [2]. 
T h e r eason for white dermogra phism in patien ts wi th atopic 
derma titis is unknown. It has been interpreted as a t rue vaso-
cons triction due to a parad oxical r esponse to acetylcholine or 
to r e lease of norepinephrine from nerve endings [3-6]. Ot h ers 
h ave proposed t hat t h e pallor enti.rely or in par t might be due 
to accumulation of edem a fluid [7- 11]. 
The intense white line th at atopic skin sh ows after stroking 
is similar to a characteristic bla nching phenomenon of th e skin 
after injection of acetylcholine-like drugs. In m ost of th e pj'e-
vious r eports the conclus ion concerning a bnormal vascular r e-
sponse in whi te dermogra phism is based on s tudies of the 
d elayed blanch r eaction. 
Using th e atraumatic local "J3Xe-washout technique [12] we 
h ave examined t he cuta neous blood flow before, d ur ing and 
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a fter white dermog:ra phism in patients wit h atopic dermatitis, 
a nd after th e sam e rubbing stim ulus in 6 normal subjects. 
MATERIALS AN D METHODS 
S ubjects 
Studies were conducted on 7 patients with well-documented atopic 
dermatit is and a contro l group of 6 normal healthy persons with no 
history of atopic disease or any dermatological complaints. Age and 
sex aJ'e seen in Tables I and II. Five of the patients had acute or chronic 
eczematous lesions at the site of examination (A, B, C, E, G) , while the 
other 2 were in a state of remission at the time of testing. T he skin area 
with the most pronounced and well-defined white dermographism was 
studied. None of the patients had smoked at least 3 hr before the study 
and the skin was un treated at least 2 days before the investigation. 
In fo rmed consent was obtained from each subject. 
Test Trauma Procedure 
Rubbing was carried out with a wooden spatula stroked over 4 cm 
length in 3 to 4 parallel lines in .order to cover the tracer marked skin 
area, and with a degree of pressure causing the subjects slight discom-
fo rt. T his procedure lasted 10-15 seconds. The examined skin area is 
seen in Tables I and II. 
Cutan.eous Blood Flow Measurem.ellts 
Skin blood flow was measured by the I:J"xenon method as described 
by Sejrsen [121- A skin aJ'ea of 2 cm in diameter was labeled with 
'''''xenon, using the atraumatic epicutaneous labeling technique. A 
NaI(Tl) scintillation detector was placed 5 cm above the radioactive 
fie ld and connected to a printing gammaspectrometer with a window 
set aJ'ound the 0.081 MeV photopeak of '''''xenon. The activity was 
printed out in in tervals of 10 seconds starting immediately after label-
ing. T he undisturbed washout curve of the tracer was fo llowed for 6-10 
min prior to the rubbing stimulus. The disappearance of the t.racer was 
fo llowed fo r an addit ional 40-50 min after the rubbing. The '''''xenon 
wa hout curve fo llowing epicutaneou labeling bends spontaneou ly 
due to accumulation of tracer in subcutaneous tissue. '''''Xenon is highly 
soluble in lipid and the rate of removal [Tom subcutaneous fat is slow. 
The washout curve was resolved in the fo llowing manner: After sub-
traction of background activity the monoexponential clearance of '''''Xe 
from subcutaneous fat was identified after 25-30 min. The curve was 
extrapolated to time zero and subtracted from the total washout curve 
resulting in another monoexponentia l plot, which represents the dermal 
cleaJ'ance component (Figure) . 
The cutaneous blood fl ow, F, was calculated from the half-time(T, d 
